Supplements in the News

Omega-3 Supports Major Depressive Disorder
 
Published Saturday, May 3, 2008 4:00 am

TEHRAN, IranA recent trial study at Tehran University of Medical Sciences compared eicosapentaenoic acid (EPA) and fluoxetine (Prozac), separately and combined, in major depressive disorder (Aus N Eng J Psych. 2008;42(3):192-98). Sixty outpatients, diagnosed with major depressive disorder, were randomly assigned either 1000 mg/d of EPA, 20 mg/d of fluoxetine or a combination for eight weeks. The combination of EPA and fluoxetine was significantly better than fluoxetine or EPA alone from the fourth week of treatment. Fluoxetine and EPA appeared to be equally effective in controlling depressive symptoms. The response rates were 50 percent, 56 percent and 81 percent in the fluoxetine, EPA and combination groups, respectively.

This abstract provided courtesy of Natural Products Industry Insider, published byVirgo Publishing Inc.



Send this page to a friend  |  Show Other Stories

Live Your Healthiest Life!
Click here for information on a variety
of health topics.

Find Answers
Vitamins A to Z
Click here for information on vitamins,
minerals, supplements and herbs

Find Answers
About | For Industry | Lookup | In the News | Newsletter | Donate
Natural Products Foundation
Copyright 2015 Natural Products Foundation | Privacy Policy | Disclaimer